NIH-funded research R01 grant

Imaging artery disease in people with cocaine use

Official title: Atherosclerosis in cocaine addiction: imaging risk with PET/MR

Funded at Icahn School of Medicine at Mount Sinai · NIH-11304519 · Data updated 2026-11-12

This project uses PET/MR scans with a glucose tracer to find early artery inflammation and plaque in people who use or used cocaine.

More Atherosclerosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$749,074
NIH project number5R01DA049547-05
Project IDNIH-11304519 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with current or past cocaine use—especially long-term users and older individuals at higher vascular risk.

Less likely to help

People without a history of cocaine exposure or those who already have advanced, symptomatic arterial disease are unlikely to benefit from this early-detection imaging.

What this research studies

If you have used cocaine, this program uses a combined PET and MRI scan to look inside your carotid arteries for inflammation and plaque before symptoms appear. The PET scan uses a small amount of 18F-FDG (a sugar tracer) to highlight inflamed vessel walls while the MRI provides detailed 3D images of plaque and vessel structure. Scans are performed simultaneously on a hybrid PET/MR machine so clinicians can match inflammation to specific plaque features. Detecting disease early could help guide preventive care for aging people who used cocaine and often also used tobacco or alcohol.

Why it matters

Potential benefit: If successful, this could allow earlier detection of artery disease in people with cocaine exposure and help prevent strokes.

How similar studies have gone: PET/MR with 18F-FDG has detected vessel inflammation in other at-risk groups, but applying this combined approach to people with cocaine use is novel.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Alia-Klein, Nelly — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Alia-Klein, Nelly

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.